Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 modified double-blind multicenter study of investigational quadrivalent meningococcal conjugate vaccine in healthy Chinese infants and toddlers
CTR20262427Phase 3Active
- Sponsor
- Sanofi
- Start
- Aug 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Meningococcal ACWY conjugate vaccine in meningococcal disease, sponsored by Sanofi. Started Aug 2026; status: active.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on CTR20262427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262427.